Oncogenic CDK13 mutations impede nuclear RNA surveillance.

Area of Science:

• Molecular Biology
• Cancer Biology
• Genetics

Background:

• RNA surveillance pathways are critical for maintaining RNA integrity by degrading defective transcripts.
• Disruptions in nuclear RNA surveillance have been linked to oncogenesis.
• Cyclin-dependent kinase 13 (CDK13) mutations are observed in melanoma, suggesting its role in cancer development.

Purpose of the Study:

• To investigate the role of CDK13 in nuclear RNA surveillance and its impact on melanoma.
• To determine the mechanism by which CDK13 mutations contribute to aberrant RNA stabilization and cancer progression.

Main Methods:

• Utilized zebrafish models with patient-derived CDK13 mutations to study melanoma acceleration.
• Investigated the phosphorylation of ZC3H14 by CDK13 and its role in nuclear RNA degradation.
• Analyzed the consequences of aberrant RNA stabilization and translation in cancer development.

Main Results:

• Mutations in CDK13 were found to accelerate melanoma in zebrafish, correlating with aberrant RNA stabilization.
• CDK13 is essential for ZC3H14 phosphorylation, a key step in promoting nuclear RNA degradation.
• Mutant CDK13 impairs nuclear RNA surveillance, leading to the stabilization and translation of aberrant protein-coding transcripts.
• Recurrent mutations in nuclear RNA surveillance genes were identified across various malignancies.

Conclusions:

• Nuclear RNA surveillance acts as a tumor-suppressive pathway.
• Activating nuclear RNA surveillance is crucial for preventing the accumulation of aberrant RNAs and mitigating their oncogenic potential.
• CDK13 plays a vital role in maintaining RNA fidelity through nuclear RNA surveillance, and its disruption drives melanoma progression.